Arena Pharmaceuticals (ARNA.O) said its experimental obesity drug helped patients shed only about 10 pounds more than those taking placebos, sending its shares down 27 percent.
Sourse: More Info
Monday, March 30, 2009
Arena obesity drug disappoints; shares fall
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment